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Available online 25 January 2020Introduction: Continuous spike–wave of sleep (CSWS) syndrome is one of the most common epileptic encepha-
lopathies of childhood. Because the associated cognitive/behavioral disturbances relate more to the amount of
spike activity than of seizures, methods of spike quantification gained relevance in diagnosis and monitoring
treatment. The conventional methodology for quantification of spike index (SI) relies on repeated full 10–20
long-term ambulatory electroencephalography (aEEG), which is both expensive and poorly tolerated.
Objective: The objectives of this studywere to demonstrate the clinical value of repeated SI assessments in CSWS
and to build and validate a wearable device allowing inexpensive and well-tolerated, repeated quantifications.
Methods: A group of N=38 patients with CSWSwere submitted to repeated SI quantifications based on aEEG, as
seen fit by themedical clinical assistant. Responses to therapy with corticosteroids (N= 10), sulthiame (N= 7),
and the ketogenic diet (N=3)weremonitored.We used a conventional method based on a semiautomatic tem-
plate match spike search. The individual variability in time spans of days (N = 4) or months (N = 10) was
assessed and used to determine the meaningful neurophysiological responses to the diverse therapies.
A wearable device capable of recording 2 bipolar EEG channels for 24 h was used to simplify SI quantification.
Results: Corticosteroids produced the most powerful SI reduction, but a large individual variability in both
amount and time of onset of clinical response with some patients exhibiting recurrence shortly after therapy.
A more frequent sampling of SI would provide a more accurate follow-up, with clinical benefit.
The comparison of the SI obtained from standard 10–20 electrodes and 2 bipolar EEG channel subsets in aEEG or
between the 10–20 and simultaneous wearable recordings, demonstrated that the newmethod provides an ac-
curate SI quantification.
Conclusions: Awearable EEG device with 2 bipolar channels simplifies the process of obtaining repeated SI quan-
tification allowing a more accurate follow-up of spike activity in the clinical setting.






The continuous spike–wave of sleep (CSWS) syndrome, first de-
scribed in 1971 [1], is a condition of young children where onset of cog-
nitive/behavioral problems (reviewed in [2]) associates with a peculiar
type of spike activity, reduced in rapid eye movement (REM) sleep and
wakefulness but very abundant during non-REM sleep. The association,
strongly suggestive of a causal relationship [3], motivated efforts to
quantify the interictal spike activity to distinguish it from similar EEG
conditions, but without the cognitive effects, and to monitor response
to therapy. Early attempts to quantify the spike index (SI) focused on
determining the percentage of non-REM sleep with continuous spiking,
using diverse, mostly poorly described, methods (reviewed in [4]). No002 Lisboa, Portugal.clear-cut threshold of the SI was firmly established for the appearance
of cognitive/behavioral problems and the early proposal of 85% in the
original article [1] persisted as a general historical reference. The intro-
duction of digital EEG in the clinical settings allowed the introduction of
more objective and less labor-intensive methods [5], with a significant
contribution from the ambulatory electroencephalography (aEEG) to
make the task of recording whole night EEG easier.
The significant variability of clinical and neurophysiological features
of CSWS throughout the course of the condition, which can extend from
the early years of life until adolescence (reviewed in [6]), and the need
for prolonged, often poorly tolerated [7], therapies has always func-
tioned as a strong motivation for the objective quantification of spike
activity as a monitoring tool (reviewed in [8]). In the clinical setting,
the adoption of methods based on repeated aEEGs for detailed analysis
has faced with practical difficulties and led to the persistent use of rou-
tine sleep studies for such assessments, despite their well-known
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aEEG for monitoring of CSWS, including cost, tolerability, and availability.
These limitations led to relatively little data on the individual variability
along the natural history of the condition and on the time relationship
with recovery from the cognitive/behavioral impairments [8].
In the present paper we proposed to a) determine the variability of
SI quantifications over a day-to-day or several months temporal span;
b) explore the temporal profile of response to themost common thera-
pies; c) quantify the SI with a full 10–20 montage and with a reduced
montage with 2 bipolar electrodes in the same patients; and d) validate
a wearable EEG logger to perform repeated SI quantifications through-
out the natural history of CSWS.
2. Patients and methods
2.1. Clinical population
The clinical population (N=38)was selected frompatients referred
to the Electroencephalography Lab of the Department of Pediatric Neu-
rology of Centro Hospitalar Lisboa Central (Lisbon, Portugal) or to the
Clinical Neurophysiology Department of Centro Hospitalar Psiquiátrico
de Lisboa (Lisbon, Portugal), with the suspicion of CSWS. In all cases,
cognitive and/or behavioral problems were associated with a sleep
EEG demonstration of strong increase in spike activity at sleep onset
and throughout. The diagnosis of CSWSwas established by demonstrat-
ing a sudden increase in the spike index (SI) to values higher than 85% in
the transition fromwakefulness to the first cycle of sleep in a 24 h aEEG
using the full 10–20 system. Cases where it was not possible to record
an all-night EEG or with abundant spike activity while awake were
excluded.
Clinical and neurophysiological data for each patient are presented
in Table 1.
2.2. EEG recordings
Recordings with the full 10–20 system were obtained in a clinical
context using a medical grade aEEG system (TREX HD, XLTEK©), with
sampling at 200 Hz and bandwidth 0.5–70 Hz. Both the timing and
the number of recordingswere freely determined by the clinical neurol-
ogists as they saw fit to support clinical decisions. Most studies lasted
24 h, but in four cases, it was extended to 67 h, including 3whole nights
(Fig. 1b). Gold-plated disk-type Grass electrodes were applied with col-
lodion and impedances adjusted to less than 5 kohm.
2.3. Spike quantification
The spike quantification was performed in the CURRY6 software
(Neuroscan-Compumedics) andMatLab (R2018a) and included the fol-
lowing steps (Fig. 1a):
Visual inspection by an experienced clinical neurophysiologist of the
raw EEG and selection of representative spikes to quantify.
Offline automatic template match search of similar spikes in the
whole recording.
Selection of spikes with higher than 85% correlation and 60% peak
amplitude with respect to the template spike.
The peakdetection timeof the remaining spikeswas used as input to
the script published by Larsson et al. [5], running inMatlab. Epochs of 3 s
were used for discretizing the trace in on–off periods, [10], and the per-
centage off on periods in 200 consecutive epochs, yielding a SI number
for each 10 min of recording.
The maximum SI for each of the first four sleep cycles were deter-
mined and averaged to obtain avgSI. The first, maxSI1, and fourth,maxSI4, were also individually selected. Those three parameters were
used to represent each assessment of SI.
2.4. Clinical response
The clinical response (CR) to therapeutic trials was retrospectively
obtained from the individual medical records of each patient, with an
emphasis on information on developmentalmilestones, behavior, inter-
personal interaction, and school performance. The clinical impression
was formulated by a medical clinical neurophysiologist (AL) and was
used to classify each therapeutic trial into one of three options: no CR
(no improvement in behavior or school performance), fair CR (detect-
able improvement in one of the previous two domains), and good CR
(clear improvement in both behavioral and school performances).
2.5. Wearable EEG device
Oneof the authors (TM) constructed a logger (Neury)with the capa-
bility to continuously acquire and store EEG from two bipolar channels
at 200 Hz (band-with 0.5–70 Hz), using standard scalp disk electrodes.
The device uses an Intan Technologies RHD2216 amplifier chip, and the
data are stored in an internal memory (128MB). The dimensions are 53
× 32 × 15 mm, and the weight is 35 g, including an internal Li-ion re-
chargeable battery (Fig. 3c). During the procedure, the device is at-
tached to the chest of the patients below the clavicle, using a snap
EKG gel electrode which can also function as electrical ground. For the
validation studies, the electrodes of the logger were applied 1 cm
apart from electrode positions of a medical grade aEEG device (TREX,
XLTEK®) so that EEG from the two devices could be compared for the
various rhythms and graphic elements.
The position of electrodes on the scalpwas establishedby the clinical
neurophysiologist with the aim of recording with the maximal ampli-
tude the spikes selected for quantification in previous clinical sleep
EEG recordings (either short- or long-term). At the end of the recording,
the EEG signal is downloaded to a PC through a mini-USB port connec-
tion in the device. The study has been approved by the ethics committee
of Centro Hospitalar Psiquiátrico de Lisboa..
3. Results
3.1. Stability of spike maps and temporal profiles in CSWS
In order to evaluate the variability of SI in multiple quantifications,
we compared its parameters in two assessments months apart (aver-
age: 1.14 years) in the same patient, with no changes in drug therapy.
Of the three parameters tested, the avgSI proved to be the one with
less variability in the 10 patients tested (Fig. 1c), with a range between
assessments of −6.6 to +13% (Fig. 1c).
In general, the spike topography of themost abundant spikes used as
templates was similar in the two assessments, except for one patient in
which bilateral independent central-parietal spikes shifted hemisphere
dominance between studies.
The daily variability was studied in four patients, with continuous
recordings spanning three nights. A similar profile of the SI can be
seen for the successive nights and naps of each patient (Fig. 1b, left),
but some changes in the avgSI can be appreciated (Fig. 1b, right).
3.2. Variation of spike temporal profile with therapy
The effect of pharmacological therapy on the SI profile was studied
using the avgSI, as this was the parameter with less variability in the
previous assessments. In Fig. 2, the changes after the most used thera-
pies are shown, together with the range of temporal variability previ-
ously determined (Fig. 1c).
In 8 of the 10 patients submitted to corticosteroids, it was possible to
reduce the avgSI to a value lower than the previous range of normal
Table 1
Patient data.









MRI Corticosteroids Sulthiame Ketogenic
diet
1
9 M 5 y CPS N GTCS School performance N Right occipital 7 y 6 Normal 9 m (8 y)
2




5 y 1 Normal
3




N Vertex 8 y 2 Normal
4
20 M 5 y CPS Language, memory N Left central 9 y 3 Thal lesion 12 m (10 y) 6 m (11 y)
5
7 F 4 y CPS None N Bilateral occipital 6 y 1 Normal
6
15 F 8 y PMS N GTCS Language N Bilateral central 8 y 2 Normal
7
16 F 5 y PMS School performance N Vertex 9 y 2 Thal lesion 6 m (9 y)
8




5 y 7 Normal 12 m (8 y)
9
15 M 2 y PMS + CPS Moderate delay N Bilateral central 8 y 3 Normal 12 m (8
y)
10
9 M 4 y CPS N GTCS Moderate delay N Right posterior
quadrant
8 y 1 Right hemisph
stroke
11
11 M 5 y PMS N GTCS School performance N Right temporal 8 y 4 None (8 y)⁎⁎
12
16 M 8 y Nocturnal
PMS
Attention N Vertex 9 y 3 Normal
13
16 M 7 y GTCS School performance,
language





11 M 8 y CPS N GTCS School performance,
aggression
N Left central +
temporal
9 y 7 Normal 6 m (9 y) 8 m (8 y)
15
11 F 2 y PMS None N Vertex 5 y 2 Normal
16
12 F 3 y PMS N GTCS School performance N Vertex 6 y 6 Normal 14 m (4 y) (5 y)⁎⁎
17
8 F PMS N GTCS Severe delay N Right posterior
quadrant
7 y 1 Brain
malformation
18
25 M 3 y PMS None N Right posterior
quadrant
10 y 1 Thal lesion
19
14 M 8 m PMS Moderate delay N Left frontal 8 y 3 Thal lesion
20
16 M 7 m PMS + CPS Severe delay N Right posterior
quadrant
10 y 7 Thal lesion (11 y)⁎⁎
21
11 F 4 y Aphasic Sensory aphasia N Left posterior
quadrant
4 y 1 Normal
22
11 M 2 y PMS School performance N Right posterior
quadrant




Moderate delay N Right central 8 y 1 Normal
24
9 F 2 y PMS Aphasia N Left temporal 3 y 2 Normal
25
9 M – – Aphasia N Bilateral
temp-parietal
6 y 1 Mild
hydrocephalus
26
11 M 4 y PMS Sensory aphasia N Left temporal 5 y 3 Normal
27






9 y 3 Normal
28
17 M 4 y PMS Sensory aphasia N Left posterior
quadrant
5 y 7 Normal 12 m (6 y)
28
10 F 1 y PMS + CPS None N Vertex 10 y 2 Thal lesion
30
9 M – – School performance,
attention, aggression
N Bilateral central 8 y 1 Normal
31
12 F 2 y PMS N GTCS School performance N Right posterior
quadrant
8 y 7 Thal lesion 5 m (8 y)
32
6 M 1 y Nocturnal
PMS
N Right central 10 y 1 Normal
33
10 M 4 y Nocturnal
PMS





N Right central 9 y 5 Normal 6 m (9 y) 12 m (10
y)
35
11 F 1 y CPS + SPS General delay Slow Right posterior
quadrant
2 y 2 Thal lesion
36
3 F 2 y PMS Language, autistic
regression
Slow Left central 3 y 1 None
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Table 1 (continued)









MRI Corticosteroids Sulthiame Ketogenic
diet
37
8 M 4 y PMS Language N Left
temporal–parietal
3 y 8 Normal 13 m (5 y), 8
m (7 y)
38
4 M – – Language, aggression N Left central 4 y 1 None
CPS—complex partial seizures; PMS—partial motor seizures; GTCS—generalized tonic–clonic seizures; aEEG—ambulatory EEG.
⁎ Duration in months (m), age of onset in years (y).
⁎⁎ Ongoing therapy.
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sponse (Fig. 2a). The time necessary to obtain a response proved highly
variable, with some patients reaching it after 3–4 months (patients P1
and P37) while others only achieved it after longer periods (P26 and
P14). The amount of the response was also very variable, with some pa-
tients demonstrating a strong one (P1 and P37), while in the remaining,
it was more modest.
Four of the responders presentedwith a late recurrence (P1, P8, P22,
P34). The two nonresponders (P16, P26) were only assessed long after
therapy onset, and so we cannot exclude that a short-term response
might have occurred.
The 7 patients submitted to therapy with sulthiame showed mean-
ingful responses in 4 cases, which were more modest in amplitude
than the ones for corticosteroids (Fig. 2b). A notable exception was pa-
tient P13 who exhibited a strong response.
In three patients submitted to ketogenic diet, it was not possible to
demonstrate a meaningful neurophysiological response (Fig. 2c). Nev-
ertheless, the follow-up is short on two cases, which precludes a defin-
itive statement.
An important limitation of the previous analysis is imposed by
the sparse assessments after therapy, which is probably a multifactorial
consequence of poor tolerability of the child population to repeated
aEEG recordings and to the economic burden associated with
such studies.
3.3. Correlation of temporal spike profiles from full 10–20 and 2 bipolar
channel montages
In order to simplify the process of repeated assessments of the SI pa-
rameters, we performed quantification of these parameters using the
full set of 10–20 electrodes and a reduced set of 2 bipolar channels ob-
tained from the same pretreatment recordings. The two bipolar chan-
nels were composed individually for each patient in order to
maximize the amplitude of the spikes that the clinical neurophysiologist
considered adequate for quantification.
Results of the paired comparison of the avgSI for 19 and 2-channel
datasets are represented in Fig. 3a and demonstrate a range from
−8.2 to+7.4%with an average difference of−1.8%. A paired t-test pro-
duced a score of 0.0617which leads to acceptance of the null hypothesis
of no difference between the two dataset means at p b 0.05.
3.4. Validation of Neury 2-channel recording with simultaneous 10–20
montage
The good overlap of the SI obtained from the full 10–20 datasets and
a selected 2 bipolar channelmontage led us to design a wearable device
(Fig. 3c), able to record two bipolar channelswithmedical grade quality
for 24 h, with the goal of simplifying the process of quantification of
spike activity in the clinical setting.
The Neury device was validated against a medical grade aEEG re-
corder in a group of healthy subjects and then in patients with epilepsy
submitted to clinical studies. A side by side comparison of the back-
ground rhythms and spike activity revealed an excellent concordancebetween the two devices, which was also apparent when comparing
ictal recordings (Fig. 3b, below).
The typical application time of the Neury device, including con-
nection of 4 electrodes on the scalp with collodium and placement
on an ECG chest snap electrode, which functions both as electrical
ground and support for the device, was around 15 min. This was
much less than the typical 60–90 min for setting up the full 10–20
system montage. The tolerability of the Neury device was also re-
ported as excellent by the patients, with no interference reported
in the daily activities.
The comparison of the SI obtained from the medical grade device
and the Neury in patients with CSWS was within the variation range
of the previously performed comparison of 19 referential to 2 bipolar
electrodes (Fig. 3d), with an average difference of −2.8%.
4. Discussion
The quantification of the SI in a group of patients with CSWS
highlighted the ability to simplify the conventional methodology with
the use of a small wearable EEG logger, with a relevant reduction of
the recording preparation time and improved tolerability, both of
which can contribute to increasing patient adherence to a more fre-
quent sampling of the SI throughout the natural history of the condition,
allowing a better characterization of the natural and therapy-induced
changes in the SI.
The analysis of the SI in our group of patients demonstrated an inter-
individual variability which was of the same magnitude of the one
found in previous studies (reviewed in [8]), ranging from average
values higher than 85% to values less than 50% (Fig. 3a). The individual
variation of the SI in the same patient several months apart, with no
change in therapy, wasmuch less (Fig. 1c) than the day-to-day variabil-
ity (Fig. 1b). Our observations support the usefulness of individual as-
sessments of the SI throughout the natural history of the syndrome as
an effective monitoring method and provide us with normality ranges
of variability to evaluate the effectiveness of therapeutic trials to reduce
the spike activity at the heart of the CSWS.
The follow-up of SI in cases submitted to the most common therapies
supports thewell-knownhigher effectiveness of corticosteroids over both
sulthiame and the ketogenic diet (reviewed in [7]) (Fig. 2), but most im-
portantly puts in evidence a high variability in both the amount of the re-
sponse and the time required to achieve it in individual patients. In the
data fromFig. 2, a clear trend for recurrence of spike activity after stopping
corticosteroids, which likely heralds clinical deterioration, can also be
found. A more detailed assessment of the individual profile of the re-
sponses to therapy onset and offset would benefit from a more frequent
sampling of the SI than the one typically used in our study and in most
clinics at the present time. Such improved sampling would provide the
chance to determine the temporal relation between changes in the SI
and clinical worsening/improvement, which is not possible in our current
study because of the sparse SI determinations available.
Because of the significant morbidity associated with corticoste-
roids, and the need for long-term trials, a fast and consistent method
of assessing the clinical effects is highly desirable so that doses can be
Fig. 1. a)Methodological steps for the quantification of SI parameters, fromEEGvisual inspection (left) to thefinal all-night SI profile (right). b) Continuous SI curve of four patients (P19, P18, P1, and
P35) with three all-night recordings. A similar profile is apparent in several nights, with a small variability in the avgSI quantified on the right graph. c) Variability in the SI parameters between two
assessments separated by severalmonths (average: 1.14 years)with no change of therapy. The avgSI parameter is the onewith less variability (−6.6% to 13%). Right, sample SI profiles for patient P7.
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Fig. 2. a) Evolution of the avgSI under therapy with corticosteroids. The duration of
therapy was variable between patients, ranging from 5 to 29 months (average: 10.6).
The normalized avgSI range time course (dotted lines in gray), revealed widely variable
maximum effect of therapy and also a variable time of onset of the neurophysiological
response. In 4 patients, a recurrent pattern after an early response is apparent in the
follow-up (P1, P22, P26, P8). b) Response for therapy with sulthiame puts in evidence a
more modest response in the avgSI, except for patient P13, which demonstrated a
strong reduction in the parameter. c) The ketogenic diet produced no clear response,
but a reduced number of patients and assessments are available.
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on cognitive/behavioral or school performance improvements to ad-
just therapy suffers from the well-known delay of these indicators in
relation to neurophysiological spike quantifications [3]. We there-
fore propose that more frequent quantification of the SI can have
an important role in timely adjustment of pharmacological thera-
pies, particularly in the ones associated with important secondary
effects.
The ability to simplify the quantification of the SIwith theuse of a re-
duced set of scalp electrodes relies on the spatial stability of spikeactivity throughout time. Our studies [11] and other's (reviewed in
[12]) suggest that the spike activity associated with CSWS remains fo-
calized in most patients, if care is taken to correct the confusing effect
of secondary propagation patterns associated with the onset of sleep.
Nevertheless, in a few cases, a clear shift in the dominant focus is appar-
ent in repeated assessments [13]. In order to overcome this possibility,
we recommend the association of a conventional nap recording,
which can provide a sensitive assessment of the spike pattern of the
first cycle of sleep [4] and inform on the spatial distribution of the dom-
inant spike activity, with a full 24-h SI assessment.
Repeated all-night quantifications of the SI are clearly more accurate
that extrapolations obtained from conventional nap recordings which
only sample the first cycle of sleep (reviewed in [4]). Some patients dem-
onstrate a clear decrease in later cycles, and a good response to therapy
can, at an early stage, be limited to those late stages of sleep and not be
apparent in the first one [8].
The proposed wearable device takes advantage of the reduced num-
ber of electrodes required for SI quantification, to minimize the weight
and inconvenience associated with conventional full 10–20 ambulatory
recorders. The additional benefits in preparation time, portability, re-
duced social impact, and freedom of movement are particularly welcome
to improve the tolerability [14] to repeated assessments in the typical
child with CSWS.
The simplification of SI quantification to a set of 2 bipolar electrodes
proved effective to sample the dominant spike patterns associated with
CSWS in our patients, and the improved signal-to-noise ratio obtained
by optimizing spike amplitudes with the individual tuning also made
more robust the selection of themore adequate spike to perform the cru-
cial template matching automatic search for spikes. This benefit is ob-
tained at the expense of decreased sensitivity to less dominant spikes
that might be present.
At the present stage, we feel that a more consistent quantification of
the SI is obtained by selecting individual spike types (eventually more
than one per patient) and performing a template match search, than
quantifying all spikes together, because not all types show the same sen-
sitivity to sleep onset [13] andmixing different types can increase noise in
the data. An additional factor that plays against detecting all spikes to-
gether relates to the fact that during sleep, secondary propagation pat-
terns frequently arise, which can artificially increase detections and
further compromise an accurate quantification.
Limitations of the paper are fundamentally its exploratory and
retrospective character, which relied on clinical decisions on the
timing of the SI quantifications and therefore led to nonuniform sam-
pling across the diverse patients. This limitation nevertheless high-
lights current clinical practices, where no clinical guidelines are
presently established on themost appropriate strategy, and supports
our suggestion that a more frequent sampling would certainly result
in a more accurate and clinically useful understanding of the individ-
ual time course of spike activity. Also, the heterogeneous number of
patients in the different therapeutic groups precludes an unbiased
comparison among them. Our goal in this respect was not so much
to make this comparison but instead to demonstrate the large vari-
ability in individual responses, which could benefit from more fre-
quent SI determinations.
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Fig. 3. a) Comparison of avgSI quantification from 10–20 montage and from the 2-channel bipolar one in N= 28 patients, left. The distribution of avgSI differences ranged from−8.2 to
+7.4%, with a mean value of−1.8%, right. b) Comparison of electrical potentials from adjacent electrodes (1 cm apart) from amedical grade device and the Neury wearable, for baseline
rhythms (upper curves), for spike activity (middle curves), and for ictal recordings (lower curves). c) Image of Neurywearable with andwithout enclosure as comparedwith 1-euro coin.
d) Comparison of avgSI quantifications from 10–20 montage (medical grade device) and from simultaneous Neury recordings in N= 6 patients. The average difference between the two
sets of data was−2.8%. Example of two all-night avgSI profiles obtained from the two devices used simultaneously in patient P14, right.
8 D. Carvalho et al. / Epilepsy & Behavior 104 (2020) 106902
9D. Carvalho et al. / Epilepsy & Behavior 104 (2020) 106902References
[1] Patry G, Luagoubi S, Tassinari C. Subclinical “electrical status epilepticus” induced by
sleep in children. A clinical and electroencephalographic study of six cases. Arch
Neurol 1971;24:242–52. https://doi.org/10.1001/archneur.1971.00480330070006.
[2] Dorris L, O'ReganM,WilsonM, Zuberi S. Progressive intellectual impairment in chil-
dren with encephalopathy related to status epilepticus during slow sleep. Epileptic
Disord 2019;21(Suppl. 1):S88–96. https://doi.org/10.1684/epd.2019.1063.
[3] Maltoni L, Posar A, Parmeggiani A. Long-term follow-up of cognitive functions in pa-
tients with continuous spike–waves during sleep (CSWS). Epilepsy Behav 2016;60:
211–7. https://doi.org/10.1016/j.yebeh.2016.04.006.
[4] Boer M. Guidelines for EEG in encephalopathy related to ESES/CSWS in children.
Epilepsia 2009;50(Suppl. 7):13–7. https://doi.org/10.1111/j.1528-1167.2009.02211.x.
[5] Larsson P,Wilson J, Eeg-OlofssonO. A newmethod for quantification and assessment of
epileptiform activity in EEGwith special reference to focal nocturnal epileptiform activ-
ity. Brain Topogr 2009;22:52–9. https://doi.org/10.1007/s10548-008-0072-3.
[6] Tassinari C, Rubboli G. Encephalopathy related to status epilepticus during slow
sleep: current concepts and future directions. Epileptic Disord 2019;21(Suppl. 1):
S82–7. https://doi.org/10.1684/epd.2019.1062.
[7] Jansen F, Nikanorova M, Peltola M. Current treatment options for encephalopathy
related to status epilepticus during slow sleep. Epileptic Disord 2019;21(S1):
S76–81. https://doi.org/10.1684/epd.2019.1061.[8] Cantalupo G, Pavlidis E, Beniczky S, Avanzini P, Gardella E, Larsson P. Quantitative
EEG analysis in encephalopathy related to status epilepticus during slow sleep. Epi-
leptic Disord 2019;21(S1):S1–S10. https://doi.org/10.1684/epd.2019.1055.
[9] Gardella E, Kolmel M, Temey D, Petersen Khinchi M, Pavlidis E, Olofsson K, et al.
Afetrnoon nap vs. all-night sleep EEG for the diagnosis of ESES. Epilepsia 2016;57
(Suppl. 2):77. https://doi.org/10.1111/epi.13609.
[10] Peltola M, Palmu K, Liukkonen E, Gaily E, Vanhatalo S. Semiautomatic quantification
of spiking in patients with continuous spikes and waves in sleep: sensitivity to set-
tings and correspondence to visual assessment. Clin Neurophysiol 2012;123(7):
1284–90. https://doi.org/10.1016/j.clinph.2011.12.001.
[11] Leal A, Calado E, Vieira JP, Mendonça C, Ferreira JC, Ferreira H, et al. Anatomical and
physiological basis of continuous spike-wave of sleep syndrome after early thalamic le-
sions. Epilepsy Behav 2018;78:243–55. https://doi.org/10.1016/j.yebeh.2017.08.027.
[12] Gibbs S, Nobili L, Halász P. Interictal epileptiform discharges in sleep and the role of
the thalamus in encephalopathy related to status epilepticus during slow sleep. Ep-
ileptic Disord 2019;21(Suppl. 1):S54–61. https://doi.org/10.1684/epd.2019.1058.
[13] Gardella E, Cantalupo G, Larsson P, Fontana E, Bernardina B, Rubboli G, et al. EEG fea-
tures in encephalopathy related to status epilepticus during slow sleep. Epileptic
Disord 2019;21(S1):S22–30. https://doi.org/10.1684/epd.2019.1054.
[14] Bruno E, Simblett S, Lang A, Biondi A, Odoi C, Schulze-Bonhage A, et al. Wearable
technology in epilepsy: the views of patients, caregivers, and health professionals.
Epilepsy Behav 2018;85:141–9. https://doi.org/10.1016/j.yebeh.2018.05.044.
